ClinicalTrials.Veeva

Menu

Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures (VA+BHD)

Stanford University logo

Stanford University

Status

Active, not recruiting

Conditions

Anxiety
Pain

Treatments

Behavioral: Bluetooth Haptic Device (BHD)
Behavioral: BHD synced with mobile game

Study type

Interventional

Funder types

Other

Identifiers

NCT06234228
73750 (Other Identifier)

Details and patient eligibility

About

This pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.

Enrollment

1,100 estimated patients

Sex

All

Ages

4 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between age 4-99
  • Will undergo a vascular access procedure
  • English speaking participant and parent or LAR

Exclusion criteria

  • Legal guardian not present to obtain consent
  • Child is unable to self-report pain or anxiety
  • Child with a significant neurological condition, or major developmental disability
  • Child with active infection of the hand or arm
  • Major surgery within the last 48 hours

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,100 participants in 3 patient groups

BHD synced with mobile game
Experimental group
Description:
At the beginning of the vascular access procedure, the BHD will be applied 5 cm above the needle insertion site and maintained in place throughout the procedure. It delivers a constant low-frequency vibration as well as tactile feedback from the game (GF).
Treatment:
Behavioral: BHD synced with mobile game
BHD only
Other group
Description:
The participant will wear the BHD 5 cm above the needle insertion site for the duration of the procedure. The BHD will deliver constant low-frequency vibration (CF).
Treatment:
Behavioral: Bluetooth Haptic Device (BHD)
Standard of Care
No Intervention group
Description:
The participant will not receive the BHD device. Participant will receive standard of care treatment.

Trial contacts and locations

1

Loading...

Central trial contact

Man Yee Suen, MMedSc; Thomas Caruso, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems